Search by Drug Name or NDC
NDC 00025-0166-08 Synarel 2 mg/mL Details
Synarel 2 mg/mL
Synarel is a NASAL SPRAY, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is NAFARELIN ACETATE.
MedlinePlus Drug Summary
Nafarelin is a hormone used to treat symptoms of endometriosis such as pelvic pain, menstrual cramps, and painful intercourse. Nafarelin also is used to treat central precocious puberty (early puberty) in young boys and girls. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 00025-0166-08Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Nafarelin
Product Information
NDC | 00025-0166 |
---|---|
Product ID | 0025-0166_bbb3315f-c436-4ae0-8374-300bf31826ed |
Associated GPIs | 30080055102020 |
GCN Sequence Number | 044984 |
GCN Sequence Number Description | nafarelin acetate SPRAY 2 MG/ML NASAL |
HIC3 | P1M |
HIC3 Description | LHRH (GNRH) AGONIST ANALOG PITUITARY SUPPRESSANTS |
GCN | 84354 |
HICL Sequence Number | 021103 |
HICL Sequence Number Description | NAFARELIN ACETATE |
Brand/Generic | Brand |
Proprietary Name | Synarel |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | nafarelin acetate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SPRAY, METERED |
Route | NASAL |
Active Ingredient Strength | 2 |
Active Ingredient Units | mg/mL |
Substance Name | NAFARELIN ACETATE |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Pharmaceutical Class | Gonadotropin Releasing Hormone Receptor Agonist [EPC], Gonadotropin Releasing Hormone Receptor Agonists [MoA] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA019886 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00025-0166-08 (00025016608)
NDC Package Code | 0025-0166-08 |
---|---|
Billing NDC | 00025016608 |
Package | 1 BOTTLE, SPRAY in 1 CARTON (0025-0166-08) / 8 mL in 1 BOTTLE, SPRAY |
Marketing Start Date | 1990-02-13 |
NDC Exclude Flag | N |
Pricing Information | N/A |